Ep-CAM overexpression in breast cancer as a predictor of survival

Lancet

Volumn 356, Issue 9246, 2000, Pages 1981-1982

  Gastl, Günther ^a   Spizzo, Gilbert ^a   Obrist, Peter ^a   Dünser, Martina ^a   Mikuz, Gregor ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

17-1A ANTIGEN; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SIZE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL TIME;

EID: 0034627152     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)03312-2     Document Type: Article

References (5)

1. Sequence investigation of the major gastrointestinal tumor-associated antigen gene family, GA733
2. The epithelial cell surface antigen, a target for antibody-mediated tumor therapy: Its biochemical nature, tissue distribution and recognition by different monoclonal antibodies
3. Detection of surface antigen 17-1A in breast and colorectal cancer
4. Ep-CAM: A human epithelial antigen is a homophilic cell-cell adhesion molecule
5. Monoclonal antibody therapy for resected Dukes' C colorectal carcinoma: Seven year outcome of a multicenter randomized trial